Skip to main content

The role of good manufacturing practices for preventing dietary supplement adulteration

Analytical and Bioanalytical Chemistry volume 405, pages 4353–4358 (2013)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. Nast C (2012) NEXT report: the natural products industry forecast 2013. New Hope Natural Media & Sterling Rice Group, Boulder

    Google Scholar 

  2. Federal Food, Drug, and Cosmetic Act of 1938. 21 U.S. Code Chapter 9. U.S. Public Law 75‐717. 52 Statutes 1040.

  3. Dietary Supplement Health and Education Act of 1994. U.S. Public Law 103–417. 108 Statutes 4325

  4. Adulterated Food. Section 402(g)(1) of the FD&C Act, Title 21 U.S. Code 342(g)(1)

  5. Adulterated Food. Section 402(a) of the FD&C Act, Title 21 U.S. Code Pt. 342(a)

  6. Prohibited Acts and Penalties. Section (301) of the FD&C Act, Title 21 U.S. Code 331

  7. Foster S (2012) The regulated dietary supplement industry: myths of an unregulated industry dispelled. HerbalGram 93:42–57

    Google Scholar 

  8. Food and Drug Administration (2007) 21 CFR 111 - current good manufacturing practice in manufacturing, packaging, labeling, or holding operations for dietary supplements; final rule. Food and Drug Administration, Rockville

    Google Scholar 

  9. Food and Drug Administration (2012) Inspections, compliance, enforcement, and criminal investigations – warning letters. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/default.htm. Accessed 25 Sep 2012

  10. Food and Drug Administration (2007) Preamble to 21 CFR 111 - current good manufacturing practice in manufacturing, packaging, labeling, or holding operations for dietary supplements; final rule. http://www.gpo.gov/fdsys/pkg/FR-2007-06-25/html/07-3039.htm. Accessed 25 Sep 2012

  11. Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements; Final Rule (2007). Title 21 code of federal regulations Pt. 111.210(h)(2)

  12. United States Pharmacopeial Convention (2012) 2012 USP dietary supplements compendium. United States Pharmacopeial Convention, Rockville

    Google Scholar 

  13. American Herbal Pharmacopeia (2011) AHP - home. http://www.herbal-ahp.org/

  14. Food and Drug Administration (2012) Guidance for industry: current good manufacturing practice in manufacturing, packaging, labeling, or holding operations for dietary supplements; small entity compliance guide. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/SmallBusinessesSmallEntityComplianceGuides/ucm238182.htm. Accessed 25 Sep 2012

  15. Food and Drug Administration (2012) Dietary supplements-import and domestic. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/ComplianceEnforcement/ucm071547.htm. Accessed 25 Sept 2012

  16. National Institute of Standards and Technology (2012) National Institute of Standards and Technology. http://www.nist.gov/index.html

  17. AOAC International (2011) AOAC International homepage. http://www.aoac.org

  18. Food and Drug Administration (1998) Bacteriological analytical manual (BAM). Food and Drug Administration, Rockville

    Google Scholar 

  19. United States Pharmacopeial Convention (2012) Food chemicals codex (FCC). United States Pharmacopeial Convention, Rockville

    Google Scholar 

  20. Roosevelt E (1960) You learn by living. Westminster John Knox, Louisville

    Google Scholar 

  21. Slifman NR, Obermeyer WR, Aloi BK, Musser SM, Correll WA Jr, Cichowicz SM, Betz JM, Love LA (1998) Contamination of botanical dietary supplements by Digitalis lanata. N Engl J Med 339(12):806–811

    Article  CAS  Google Scholar 

  22. Takagi H, Ochoa MS, Zhou L, Helfman T, Murata H, Falanga V (1995) Enhanced collagen synthesis and transcription by peak E, a contaminant of L-tryptophan preparations associated with the eosinophilia myalgia syndrome epidemic. J Clin Invest 96(5):2120–2125

    Article  CAS  Google Scholar 

  23. Food and Drug Administration (2008) Ginseng dietary supplements special survey (CFSAN assignments and field regulatory monitoring for FY 2003 and FY 2004). http://www.fda.gov/Food/FoodSafety/FoodContaminantsAdulteration/Pesticides/ResidueMonitoringReports/ucm116752.htm. Accessed 25 Sep 2012

  24. Food and Drug Administration (2009) Import alert 99–08. http://www.accessdata.fda.gov/cms_ia/importalert_259.html. Accessed 25 Sep 2012

  25. Food and Drug Administration (2010) FDA letter to manufacturers of dietary supplements re: tainted products marketed as dietary supplements. http://www.fda.gov/downloads/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/MedicationHealthFraud/UCM236985.pdf. Accessed 25 Sep 2012

Download references

Author information

Authors and Affiliations

  1. Natural Products Association, 1773 T Street NW, Washington, DC, 20009, USA

    Victoria Whitsitt & Cara Welch

  2. QSD Consulting, 717 Lower Raven Creek Road, Benton, PA, 17814, USA

    Cindy Beehner

Authors
  1. Victoria Whitsitt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cindy Beehner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cara Welch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Victoria Whitsitt.

Additional information

Published in the topical collection Functional Foods and Dietary Supplements with guest editors Melissa M. Phillips and Catherine A. Rimmer.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Whitsitt, V., Beehner, C. & Welch, C. The role of good manufacturing practices for preventing dietary supplement adulteration. Anal Bioanal Chem 405, 4353–4358 (2013). https://doi.org/10.1007/s00216-012-6663-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-012-6663-6